Eyenovia Announces Co-Branded Validator with Kinetiq

Core Insights - Eyenovia, Inc. has launched a co-branded Hyperliquid validator in collaboration with Kinetiq, marking a significant advancement in its onchain engagement strategy [1][2][3] - The validator initiative is part of Eyenovia's strategy to actively engage with ecosystem projects, potentially allowing investors to benefit from both asset performance and strategic participation [5] - Eyenovia has acquired 1,040,584.5 HYPE tokens to support network stability and security through validator operations [2][4] Company Overview - Eyenovia is a pioneering digital ophthalmic technology company and the first publicly listed U.S. company to build a strategic treasury of Hyperliquid's native token, HYPE [8] - The company is also developing the Optejet User Filled Device (UFD) for topical ophthalmic treatments, which aims to improve patient compliance and treatment outcomes [9] Hyperliquid Platform and HYPE Token - Hyperliquid is a layer one blockchain optimized for high-frequency trading, featuring onchain perpetual futures and spot order books with 70 millisecond block times [6] - HYPE, the native token of Hyperliquid, provides utility through reduced trading fees and has become the 12th-largest cryptocurrency by market capitalization, with over 25 million HYPE sequestered as of June 2025 [7]